TMCnet News
ADLM elects new leaders to serve terms starting in August 2026WASHINGTON, June 30, 2026 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce that Christina (Tina) Lockwood, PhD, DABCC, DABMGG, FADLM, has been elected to serve on the ADLM Board of Directors as president-elect starting in August 2026. Following this, Dr. Lockwood will serve successive terms as the association's president from August 2027 to July 2028 and as past president from August 2028 to July 2029.
The ADLM membership also elected a new secretary and two new directors to the association's board. They will take office in August 2026 along with the incoming president of the Academy of Diagnostics & Laboratory Medicine and the incoming chair of the ADLM Medical Laboratory Scientists Council, both of whom will also serve on the board. "I am honored that ADLM's members have chosen me to serve as president-elect of the association," said Dr. Lockwood. "Laboratory medicine is evolving rapidly, and the pace of change makes ADLM's work more important than ever. Every day, our field helps translate scientific discoveries and new technologies into better care for patients. At the same time, we must address important challenges, including improving access to testing, advancing health equity, and ensuring the responsible use of emerging tools in data science and artificial intelligence. I look forward to working with ADLM's board, staff, and members to strengthen the association's programs, foster collaboration across the field, and provide our members with the knowledge, connections, and support they need to lead during this exciting time." Dr. Lockwood is a professor of laboratory medicine and pathology at the University of Washington School of Medicine in Seattle, where she serves as division head of laboratory genetics, director of the Genetics and Solid Tumor Diagnostics Laboratory, and clinical director of the Northwest Genomics Center. She is a diplomate of the American Board of Clinical Chemistry and the American Board of Medical Genetics and Genomics, and a fellow of the Academy of Diagnostics & Laboratory Medicine. Dr. Lockwood's work advances molecular and bioinformatics approaches in clinical genomic testing, with a focus on implementation that improves patient care. She has contributed to national efforts in laboratory quality, compliance, and regulation through service with ADLM, the Association for Molecular Pathology, College of American Pathologists, Clinical Laboratory Improvement Advisory Committee, Clinical & Laboratory Standards Institute, The Joint Commission, and National Institutes of Health. Her ADLM service includes time on the Board of Directors, the Reimbursement Task Force, the Policy and External Affairs Core Committee, the Annual Meeting Organizing Committee, and editorial service with Clinical Chemistry, The Journal of Applied Laboratory Medicine, and CLN Daily. ADLM secretary Previously, Dr. Parnas was lab value lead and director of medical and scientific affairs at Roche Diagnostics USA and director of clinical chemistry at Sutter Health's Shared Laboratory. ADLM board members Additionally, Vipul C. Shah, MBA, MLS, H(ASCP), DLM(ASCP)cm, will serve on the board from August 2026 to July 2027 as chair of the Medical Laboratory Scientists Council, which guides ADLM's activities and programs to serve the professional needs of the association's medical laboratory scientist members. Dr. Tacker is a clinical professor of pathology at West Virginia University (WVU). She serves as medical director of the special chemistry and mass spectrometry sections of the J.W. Ruby Memorial Hospital Laboratory, CLIA medical director for the Fairmont Medical Center Laboratory, and WVU Medicine System lead for information technology and technology standardization. As an active ADLM member since 2001 and an Academy fellow since 2009, Dr. Tacker has served on two Annual Meeting Organizing Committees and ADLM's Publications and Policy and External Affairs Core Committees. She has also chaired the Clinical Laboratory News Board of Editors. Dr. Woodworth is clinical director for global laboratory services at CTI Clinical Trials & Consulting and has more than 20 years of experience in clinical laboratory medicine. She has served ADLM in numerous local and national leadership roles, including as a member of the ADLM Board of Directors, president of the Academy of Diagnostics & Laboratory Medicine, and chair of the Maternal-Fetal Medicine Division. She has nearly 100 publications and has held editorial board roles for Clinical Laboratory News and other ADLM publications. ADLM nominating committee Dr. Karger is a professor in the department of laboratory medicine and pathology at the University of Minnesota. Her primary clinical duties include serving as medical director of the University of Minnesota Masonic Children's Hospital clinical laboratories and biochemical genetics laboratory, and as director for point-of-care testing for the M Health Fairview system. Dr. Wiencek is an associate professor in the department of pathology, microbiology, and immunology at Vanderbilt University School of Medicine in Nashville, Tennessee. He also serves as medical director of the Vanderbilt University Medical Center Core and Emergency Department Laboratories and co-director of Vanderbilt's ComACC-accredited clinical chemistry fellowship program. Dr. Nissen is senior director and medical officer across the Point of Care and Laboratory Solutions businesses at Siemens Healthineers. She has worked in laboratory medicine and been an active ADLM member since 2008, with experience across research, hospital, clinic, and industry settings. About the Association for Diagnostics & Laboratory Medicine (ADLM) Christine DeLong Bill Malone
SOURCE Association for Diagnostics & Laboratory Medicine (ADLM) 
|
View original content to download multimedia: